PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 90 filers reported holding PLIANT THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,584,033 | -4.6% | 379,702 | -0.3% | 2.37% | -3.2% |
Q2 2023 | $6,898,773 | -17.2% | 380,727 | +21.5% | 2.45% | -23.5% |
Q1 2023 | $8,332,397 | +41.5% | 313,248 | +2.8% | 3.20% | +31.3% |
Q4 2022 | $5,887,396 | +26.5% | 304,573 | +36.7% | 2.44% | +24.1% |
Q3 2022 | $4,653,000 | +173.7% | 222,757 | +5.0% | 1.96% | +167.7% |
Q2 2022 | $1,700,000 | -3.3% | 212,210 | +14.0% | 0.73% | +18.8% |
Q1 2022 | $1,758,000 | -25.3% | 186,110 | +6.8% | 0.62% | -19.9% |
Q4 2021 | $2,353,000 | -16.3% | 174,260 | +4.7% | 0.77% | -20.2% |
Q3 2021 | $2,810,000 | -36.3% | 166,447 | +10.1% | 0.96% | -33.9% |
Q2 2021 | $4,410,000 | – | 151,111 | – | 1.46% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
Grace Capital | 48,058 | $808,000 | 0.50% |
Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |